lovastatin has been researched along with Weight Loss in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breslow, JL; Cruz, DE; Garbarino, J; Riegelhaupt, JJ; Waase, MP | 1 |
| Cukierski, MA; Lankas, GR; Wise, LD | 1 |
| Granegger, S; Mayr, F; O'Grady, J; Peskar, BA; Schmid, P; Sinzinger, H | 1 |
| Kuiper, JJ | 1 |
| Autier, P; Muls, E; Van Gaal, L; Vansant, G | 1 |
| Avery, BR | 1 |
| Grundy, SM | 1 |
| Asahara, H; Kira, J; Ohyagi, Y; Shinnoh, N; Taniwaki, T; Yamada, T | 1 |
1 review(s) available for lovastatin and Weight Loss
| Article | Year |
|---|---|
Consensus statement: Role of therapy with "statins" in patients with hypertriglyceridemia.
Topics: Cholesterol, HDL; Cholesterol, VLDL; Clinical Trials as Topic; Consensus Development Conferences as Topic; Coronary Disease; Drug Therapy, Combination; Exercise; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Hypolipidemic Agents; Lipoproteins; Lovastatin; Niacin; Pravastatin; Risk Factors; Simvastatin; Triglycerides; Weight Loss | 1998 |
8 other study(ies) available for lovastatin and Weight Loss
| Article | Year |
|---|---|
[Dyslipidemia. Red rice supplements change in nutrition].
Topics: Anticholesteremic Agents; Combined Modality Therapy; Dietary Supplements; Humans; Hypercholesterolemia; Life Style; Lovastatin; Oryza; Randomized Controlled Trials as Topic; Weight Loss | 2014 |
Targeted disruption of steroidogenic acute regulatory protein D4 leads to modest weight reduction and minor alterations in lipid metabolism.
Topics: Absorptiometry, Photon; Animals; Body Mass Index; Cholesterol; Dietary Fats; Eating; Female; Fertility; Gallbladder; Gene Expression Profiling; Gene Expression Regulation; Gene Knockout Techniques; Glucose Tolerance Test; Lipid Metabolism; Liver; Lovastatin; Male; Membrane Transport Proteins; Mice; Organ Size; Protein Structure, Tertiary; RNA, Messenger; Sterols; Time Factors; Weight Loss | 2010 |
The role of maternal toxicity in lovastatin-induced developmental toxicity.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Animals; Area Under Curve; Body Weight; Bone and Bones; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Embryo, Mammalian; Female; Fetal Weight; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Lovastatin; Maternal Exposure; Organ Size; Pregnancy; Pregnancy, Animal; Rats; Teratogens; Time Factors; Weight Loss | 2004 |
Sleep disturbance and appetite loss after lovastatin.
Topics: Adolescent; Feeding and Eating Disorders; Female; Humans; Lovastatin; Male; Sleep Wake Disorders; Weight Loss | 1994 |
Effects of weight reduction and angiotensin-converting enzyme inhibition on IgA nephropathy-associated proteinuria.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Cholesterol; Diet, Reducing; Female; Glomerulonephritis, IGA; Hematuria; Humans; Lisinopril; Lovastatin; Middle Aged; Obesity; Proteinuria; Weight Loss | 1996 |
Effects of initial BMI and on-treatment weight change on the lipid-lowering efficacy of fibrates.
Topics: Body Mass Index; Clofibric Acid; Female; Fenofibrate; Fibric Acids; Gemfibrozil; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipids; Lovastatin; Male; Middle Aged; Prospective Studies; Sex Factors; Simvastatin; Weight Loss | 1997 |
Treatment of the patient with primary familial heterozygous hypercholesterolemia.
Topics: Aged; Colestipol; Coronary Disease; Diet, Fat-Restricted; Drug Therapy, Combination; Exercise; Female; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Lovastatin; Male; Middle Aged; Niacin; Patient Compliance; Weight Loss | 1995 |
Lovastatin does not correct the accumulation of very long-chain fatty acids in tissues of adrenoleukodystrophy protein-deficient mice.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily D, Member 1; ATP-Binding Cassette Transporters; Blotting, Western; Brain; Brain Chemistry; Cholesterol; Fatty Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Liver; Lovastatin; Male; Membrane Proteins; Mice; Spinal Cord; Weight Loss | 2000 |